Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
648
-
Total 13F shares, excl. options
-
73M
-
Shares change
-
-412K
-
Total reported value, excl. options
-
$27.3B
-
Value change
-
-$163M
-
Put/Call ratio
-
1.13
-
Number of buys
-
287
-
Number of sells
-
-296
-
Price
-
$373.50
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2018
787 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2018.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 648 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73M shares
of 105M outstanding shares and own 69.56% of the company stock.
Largest 10 shareholders include Capital World Investors (7.03M shares), BlackRock Inc. (5.93M shares), Vanguard Group Inc (5.9M shares), FMR LLC (5.35M shares), STATE STREET CORP (3.27M shares), LOOMIS SAYLES & CO L P (3.16M shares), HARRIS ASSOCIATES L P (3.01M shares), WELLINGTON MANAGEMENT GROUP LLP (3.01M shares), SANDS CAPITAL MANAGEMENT, LLC (2.08M shares), and Capital International Investors (1.53M shares).
This table shows the top 648 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.